In this edition of Null and Noteworthy, the Interagency Autism Coordinating Committee grapples with “groundbreaking” research and two reviews of interventions come to conflicting conclusions.
Autism prevalence in the United States rose to 1 in 44 children in 2018, up from 1 in 54 in 2016.
One family paid more than $7,000 for their child to participate in a small clinical trial in Panama. The trial’s lead author did not disclose that detail.
Almost 60 percent of autistic people may have an average or above-average intelligence quotient, according to a new longitudinal study.
Shafali Jeste has spent the bulk of her scientific career searching for biological markers of autism. Her goal: to improve lives through early diagnosis and speedy testing of therapies.
A potential new gene therapy delivered via a single injection mimics ratios of proteins normally found in cells.
Andrew Whitehouse talks about his conservation efforts in the Australian Outback, what it’s like to be an identical twin and why he leaves work promptly at 5 p.m.
Rare variants that alter the expression of genes in the brain contribute to autism in people who also have a rare autism-linked mutation, according to a new study.
People with autism have more mutations than others do in both mitochondrial DNA and nuclear DNA that affects mitochondrial function.
Clues that problems with mitochondria contribute to autism have been accumulating for decades. In the past five years, a mutant mouse and a flurry of findings have energized the field.